Nathan John Weyand

Ohio University Athens

$528,500

Attributed

$528,500

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $453K · FY2017–25

$500K$375K$250K$125K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$528,500 · 2

By mechanism

R15$453,000 · 1

R03$75,500 · 1

Top collaborators

No co-investigators on record.

Most similar at Ohio University Athens

Same institution · by research overlap

Ronan Carroll$3,241,744

Others in their field

Other Emerging Leaders on “Bacteria”

Urs Ochsner · Crestone, Inc.$40,390,611
Ryan Cirz · Revagenix, Inc.$35,410,554
Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
Gary Fanger · Rise Therapeutics, Llc$19,697,313
Bruce Blough · Research Triangle Institute$19,637,160
Thomas Dick · Rbhs-New Jersey Medical School$14,299,891

Research focus

BacteriaCombatNeisseria GonorrhoeaeSerumHuman BodyBindingGenesInfectionResistanceCellsPilumPhenotypeGonorrheaBase SequenceBaseAntibiotic TherapyBactericideBacterial InfectionsAntibioticsAlpha CellCell PhysiologyCell LineCell CortexCd46 Antigen

Grant awards (2)

Generation and characterization of a small RNA mutant library in Neisseria gonorrhea$75,500

R03 · FY2025 · AI · contact PI

Evasion of serum killing by Neisseria gonorrhoeae using membrane-associated complement inhibitors$453,000

R15 · FY2017 · AI · contact PI